NewGenIvf Group Limited (NIVF)

NewGenIvf Group Statistics

Total Valuation

NewGenIvf Group has a market cap or net worth of $1.76 million. The enterprise value is $3.39 million.

Market Cap	1.76M
Enterprise Value	3.39M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

NewGenIvf Group has 864,912 shares outstanding.

Current Share Class	860,807
Shares Outstanding	864,912
Shares Change (YoY)	n/a
Shares Change (QoQ)	+185.91%
Owned by Insiders (%)	1.01%
Owned by Institutions (%)	2.19%
Float	856,153

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.32
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.17

Current Ratio	1.17
Quick Ratio	1.06
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.49

Financial Efficiency

Return on equity (ROE) is -53.76% and return on invested capital (ROIC) is -27.47%.

Return on Equity (ROE)	-53.76%
Return on Assets (ROA)	-17.99%
Return on Invested Capital (ROIC)	-27.47%
Return on Capital Employed (ROCE)	-135.35%
Revenue Per Employee	$71,492
Profits Per Employee	-$6,903
Employee Count	76
Asset Turnover	1.35
Inventory Turnover	34.83

Taxes

Income Tax	-486,706
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.71% in the last 52 weeks. The beta is -0.10, so NewGenIvf Group's price volatility has been lower than the market average.

Beta (5Y)	-0.10
52-Week Price Change	-99.71%
50-Day Moving Average	2.23
200-Day Moving Average	98.14
Relative Strength Index (RSI)	45.78
Average Volume (20 Days)	63,660

Short Selling Information

The latest short interest is 49,534, so 5.73% of the outstanding shares have been sold short.

Short Interest	49,534
Short Previous Month	55,312
Short % of Shares Out	5.73%
Short % of Float	5.79%
Short Ratio (days to cover)	0.12

Income Statement

In the last 12 months, NewGenIvf Group had revenue of $5.43 million and -$524,643 in losses.

Revenue	5.43M
Gross Profit	1.83M
Operating Income	-1.16M
Pretax Income	n/a
Net Income	-524,643
EBITDA	-1.14M
EBIT	-1.16M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has $1.53 million in cash and $3.18 million in debt, giving a net cash position of -$1.65 million or -$1.91 per share.

Cash & Cash Equivalents	1.53M
Total Debt	3.18M
Net Cash	-1.65M
Net Cash Per Share	-$1.91
Equity (Book Value)	-1.48M
Book Value Per Share	-46.05
Working Capital	452,391

Cash Flow

In the last 12 months, operating cash flow was -$8.26 million and capital expenditures -$53,045, giving a free cash flow of -$8.32 million.

Operating Cash Flow	-8.26M
Capital Expenditures	-53,045
Free Cash Flow	-8.32M
FCF Per Share	-$9.62

Margins

Gross margin is 33.62%, with operating and profit margins of -21.36% and -9.66%.

Gross Margin	33.62%
Operating Margin	-21.36%
Pretax Margin	-17.68%
Profit Margin	-9.66%
EBITDA Margin	-21.00%
EBIT Margin	-21.36%
FCF Margin	n/a

Dividends & Yields

NewGenIvf Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-30.18%
FCF Yield	-478.42%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 4, 2025. It was a reverse split with a ratio of 1:5.

Last Split Date	Aug 4, 2025
Split Type	Reverse
Split Ratio	1:5

Scores

NewGenIvf Group has an Altman Z-Score of 1.86 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.86
Piotroski F-Score	1